ATE383147T1 - Ophthalmische lösung - Google Patents

Ophthalmische lösung

Info

Publication number
ATE383147T1
ATE383147T1 AT01932088T AT01932088T ATE383147T1 AT E383147 T1 ATE383147 T1 AT E383147T1 AT 01932088 T AT01932088 T AT 01932088T AT 01932088 T AT01932088 T AT 01932088T AT E383147 T1 ATE383147 T1 AT E383147T1
Authority
AT
Austria
Prior art keywords
ophthalmic solution
pericorneal
vasoconstrictor
conjunctiva
ameliorating
Prior art date
Application number
AT01932088T
Other languages
English (en)
Inventor
Hisayuki Nakayama
Shuichi Nishihata
Hiroshi Aki
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE383147T1 publication Critical patent/ATE383147T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01932088T 2000-05-17 2001-05-16 Ophthalmische lösung ATE383147T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000145641 2000-05-17

Publications (1)

Publication Number Publication Date
ATE383147T1 true ATE383147T1 (de) 2008-01-15

Family

ID=18652119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01932088T ATE383147T1 (de) 2000-05-17 2001-05-16 Ophthalmische lösung

Country Status (10)

Country Link
EP (1) EP1283043B1 (de)
JP (2) JP4737911B2 (de)
KR (1) KR100776577B1 (de)
CN (1) CN1270707C (de)
AT (1) ATE383147T1 (de)
AU (1) AU2001258755A1 (de)
DE (1) DE60132325T2 (de)
ES (1) ES2295161T3 (de)
PT (1) PT1283043E (de)
WO (1) WO2001087304A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004255218A1 (en) 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
JP2005239681A (ja) * 2004-02-27 2005-09-08 Taisho Pharmaceut Co Ltd 眼科用剤
JP4961671B2 (ja) * 2004-02-27 2012-06-27 大正製薬株式会社 点眼剤
JP5434981B2 (ja) * 2004-02-27 2014-03-05 大正製薬株式会社 点眼剤
JP2005247802A (ja) * 2004-03-08 2005-09-15 Zeria Pharmaceut Co Ltd 点眼剤
JP4919666B2 (ja) * 2005-01-26 2012-04-18 ロート製薬株式会社 プラノプロフェン含有組成物
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
JP2010502564A (ja) * 2006-08-28 2010-01-28 千寿製薬株式会社 眼科用経皮吸収型製剤
RU2600863C2 (ru) * 2007-12-10 2016-10-27 Сентисс Фарма Прайвит Лимитед Офтальмическая композиция, включающая фенилэфрин
CN114099505B (zh) * 2021-12-07 2023-10-27 湖北远大天天明制药有限公司 一种眼用组合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
JP2824863B2 (ja) * 1989-07-12 1998-11-18 エーザイ株式会社 α▲下１▼―ブロッカー点眼剤
JPH04327533A (ja) * 1991-04-23 1992-11-17 Lion Corp 抗アレルギー用粘膜局所投与剤
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive

Also Published As

Publication number Publication date
ES2295161T3 (es) 2008-04-16
DE60132325D1 (de) 2008-02-21
EP1283043B1 (de) 2008-01-09
JP2011093923A (ja) 2011-05-12
DE60132325T2 (de) 2009-01-02
EP1283043A1 (de) 2003-02-12
AU2001258755A1 (en) 2001-11-26
KR100776577B1 (ko) 2007-11-16
CN1438886A (zh) 2003-08-27
PT1283043E (pt) 2008-02-07
CN1270707C (zh) 2006-08-23
WO2001087304A1 (en) 2001-11-22
EP1283043A4 (de) 2003-07-02
JP4737911B2 (ja) 2011-08-03
KR20030001490A (ko) 2003-01-06

Similar Documents

Publication Publication Date Title
DE60132325D1 (de) Ophthalmische lösung
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
BR0016386A (pt) Lentes oftálmicas multifocais birrefringentes refrativas hìbridas
DE60218633D1 (de) Inhibitoren von cruzipain und anderen cysteinproteasen
ECSP044862A (es) Pirenzepine ophthalmic gel
EP1515722A4 (de) Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
NO20052751D0 (no) Oftalmisk preparat for behandling av okulaer hypertensjon.
EP1581503A4 (de) Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie
ITRM20010438A0 (it) Preparato oftalmico a base di n-acetilcisteina per il trattamento della sindrome dell'occhio secco.
NO993647L (no) Endotelinantagonist
HRP20031057B1 (hr) Tableta koja sadrži cetirizin i pseudoefedrin
EP1515721A4 (de) Ophthalmische zusammensetzungen zur behandlung der okularen hypertonie
BRPI0412721A (pt) processo para preparar bromidrato de eletriptano alfa-polimórfico
EP1262195A4 (de) Vasoaktieve agentia
DK0813870T3 (da) Anvendelse af darifenacin til at forstærke kognitive funktioner
BR0016941A (pt) Derivados de aminometil-fenil-ciclohexanona
FR2803922B1 (fr) Lentille ophtalmique
IT1314486B1 (it) Torcia per attivita' subacquea.
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
DK1445641T3 (da) Okulære linser
ATE373475T1 (de) Carbamate von 2-heterozyklischen 1,2-ethandiolen
ITBA20020033A1 (it) Lente oftalmica innovativa per miopia e suoi metodi di realizzazione.
RU2001105359A (ru) Способ определения показаний к лазерному вмешательству при первичной открытоугольной глаукоме
DK0865436T3 (da) Dithiazoldioxider samt deres anvendelse som mikrobicider

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties